AFMD Affimed N.V.

2.15
+0.05  (2%)
Previous Close 2.10
Open 2.15
Price To book 1.99
Market Cap 94467511
Shares 43,938,377
Volume 135,041
Short Ratio 1.19
Av. Daily Volume 271,090

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1b update 2H 2017.
AFM13 with Keytruda
Hodgkin Lymphoma - Cancer
Phase 2a full data due 2019.
AFM13
Hodgkin Lymphoma - Cancer